Position in KALV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,072,204
New position
Shares Held
53,264
first reported quarter
Ownership
0.100%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#76
of 182 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CenterBook Partners LP holds $104,676,185 across 36 Biotechnology names. KALV ranks #20 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
171,166 | $15,213,234 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
150,912 | $11,331,982 | |
| 3 | ARGX |
Argenx SE
|
13,934 | $10,175,303 | |
| 4 | RPRX |
Royalty Pharma plc
|
157,177 | $7,539,780 | |
| 5 | INSM |
INSMED Inc
|
35,232 | $5,761,136 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
157,122 | $4,668,094 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,060 | $3,909,558 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
97,003 | $3,902,430 |
All Filings in KALV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,072,204 | 53,264 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||